We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Manufacturers of Jardiance, which contains the drug empagliflozin, which is used in the treatment of diabetes in adults, seeking approval in the US to make a version of the medicine to meet increasing demand from this group of young diabetes patients.